Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Tumor microenvironment in sporadic vestibular schwannoma: a systematic, narrative review
D Cazzador, L Astolfi, A Daloiso, G Tealdo… - International Journal of …, 2023 - mdpi.com
Although diagnosis and treatment of vestibular schwannomas (VSs) improved in recent
years, no factors have yet been identified as being capable of predicting tumor growth …
years, no factors have yet been identified as being capable of predicting tumor growth …
[HTML][HTML] Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma
Z Huo, Z Wang, H Luo, D Maimaitiming… - Neuro …, 2023 - pmc.ncbi.nlm.nih.gov
Background Vestibular schwannoma (VS) is the most common benign tumor in the
cerebellopontine angle and internal auditory canal. Illustrating the heterogeneous cellular …
cerebellopontine angle and internal auditory canal. Illustrating the heterogeneous cellular …
High-Dimensional Imaging of Vestibular Schwannoma Reveals Distinctive Immunological Networks Across Histomorphic Niches in NF2-related Schwannomatosis
Abstract NF2-related Schwannomatosis (NF2 SWN) is a rare tumour-predisposition
syndrome characterised by the growth of multiple central and peripheral nervous system …
syndrome characterised by the growth of multiple central and peripheral nervous system …
[HTML][HTML] Single-Cell and Bulk Transcriptomics Reveal the Immunosenescence Signature for Prognosis and Immunotherapy in Lung Cancer
Y Zhang, J Zhou, Y **, C Liu, H Zhou, Y Sun, H Jiang… - Cancers, 2024 - mdpi.com
Background: Immunosenescence is the aging of the immune system, which is closely
related to the development and prognosis of lung cancer. Targeting immunosenescence is …
related to the development and prognosis of lung cancer. Targeting immunosenescence is …
[HTML][HTML] Development of a 23-Gene Signature for Tumor Growth Mechanism in Vestibular Schwannoma
Abstract Background/Objectives: Transcriptome profiling can reveal prognostic biomarkers
and therapeutic vulnerabilities for directing clinical care. Currently, there are no biomarkers …
and therapeutic vulnerabilities for directing clinical care. Currently, there are no biomarkers …
[HTML][HTML] Spontaneous Regression of a Large Vestibular Schwannoma: Is Nonoperative Management Reasonable?
KAC Teo, R Agrwal, PL Kei, SL Lim… - Brain Tumor …, 2024 - synapse.koreamed.org
Vestibular schwannomas (VSs) are the most common cerebellopontine tumors. The natural
history of smaller-sized VSs (< 30 mm) has been well-studied, leading to the …
history of smaller-sized VSs (< 30 mm) has been well-studied, leading to the …
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma …
S Lu, Z Yin, L Wu, Y Sun, J Chen, LMN Wu, JL Oblinger… - bioRxiv, 2024 - biorxiv.org
Background NF2-related schwannomatosis (NF2-SWN) is a debilitating condition that calls
for robust treatment options. The defining feature of NF2-SWN is the presence of bilateral …
for robust treatment options. The defining feature of NF2-SWN is the presence of bilateral …
Direct and abscopal anti-tumor responses elicited by peripheral nerve schwannoma irradiation synergize with anti-PD1 treatment in vestibular schwannoma models
Z Yin, S Lu, L Wu, Y Sun, DW Blake, J Chen… - bioRxiv, 2024 - biorxiv.org
Abstract NF2-related schwannomatosis (NF2-SWN) is a progressive and disabling disease
requiring effective treatments. The hallmark of NF2-SWN is bilateral vestibular …
requiring effective treatments. The hallmark of NF2-SWN is bilateral vestibular …
The tumour microenvironment in Vestibular Schwannoma
C Hannan - 2023 - search.proquest.com
Background Previously, Vestibular Schwannomas (VS) were thought to arise as a
consequence of the clonal expansion of neoplastic Schwann cells, but more recently there …
consequence of the clonal expansion of neoplastic Schwann cells, but more recently there …